Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 12:28 AM
Study NCT ID:
NCT05137860
Status:
UNKNOWN
Last Update Posted:
2022-01-18
First Post:
2021-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Sponsor:
Hospital General de Mexico
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06-23
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-16
First Submit QC Date:
None
Study First Post Date:
2021-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-02
Last Update Post Date:
2022-01-18
Last Update Post Date Type:
ACTUAL